Alpha 2.0
Login Register
» Articles » PMID: 30652313

Batch-to-Batch and Within-Subject Variability: What Do We Know and How Do These Variabilities Affect Clinical Pharmacology and Bioequivalence?

Overview
Journal Clin Pharmacol Ther
Publisher Wiley
Specialty Pharmacology
Date 2019 Jan 18
PMID 30652313
Citations 3
Authors
Leslie Z Benet
Priya Jayachandran
Kevin J Carroll
Elise Burmeister Getz
Affiliations
Soon will be listed here.
Citing Articles

Analysis on the Impact of U.S. FDA's Narrow Therapeutic Index Bioequivalence Criteria on Generic Drug Applications.

Anim Anno K, Mina M, Zhang Z, Zhang L, Jiang W AAPS J. 2025; 27(1):42.

PMID: 39939514 DOI: 10.1208/s12248-025-01020-1.

Exploration of the potential impact of batch-to-batch variability on the establishment of pharmacokinetic bioequivalence for inhalation powder drug products.

Li S, Feng K, Lee J, Gong Y, Wu F, Newman B CPT Pharmacometrics Syst Pharmacol. 2024; 14(2):331-339.

PMID: 39575671 PMC: 11812940. DOI: 10.1002/psp4.13276.

A Two-Way Proposal for the Determination of Bioequivalence for Narrow Therapeutic Index Drugs in the European Union.

Paixao P, Garcia Arieta A, Silva N, Petric Z, Bonelli M, Morais J Pharmaceutics. 2024; 16(5).

PMID: 38794260 PMC: 11125232. DOI: 10.3390/pharmaceutics16050598.

Pharmacokinetic Models for Inhaled Fluticasone Propionate and Salmeterol Xinafoate to Quantify Batch-to-Batch Variability.

Li S, Feng K, Lee J, Gong Y, Wu F, Newman B AAPS J. 2024; 26(3):56.

PMID: 38671158 DOI: 10.1208/s12248-024-00913-x.

Performance of Multiple-Batch Approaches to Pharmacokinetic Bioequivalence Testing for Orally Inhaled Drug Products with Batch-to-Batch Variability.

Burmeister Getz E, Carroll K, Christopher J, Morgan B, Haughie S, Cavecchi A AAPS PharmSciTech. 2021; 22(7):225.

PMID: 34410557 PMC: 8376725. DOI: 10.1208/s12249-021-02063-1.